XML 35 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature of the Business (Details) (USD $)
In Millions, except Share data, unless otherwise specified
6 Months Ended 0 Months Ended
Jun. 30, 2013
item
Jul. 17, 2013
Subsequent events
Jul. 17, 2013
Convertible senior notes
Subsequent events
Nature of the Business      
Number of novel therapeutic oncology candidates 6    
Unrestricted cash and cash equivalents and available-for-sale securities $ 62.1    
Public Offering      
Shares of common stock sold in underwritten public offering   5,750,000  
Interest rate (as a percent)     4.50%
Notes issued     125.0
Net proceeds from sale of common stock and convertible senior notes   $ 147.4